SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-118826
Filing Date
2016-05-10
Accepted
2016-05-10 16:43:03
Documents
1
Period of Report
2016-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7400
  Complete submission text file 0001209191-16-118826.txt   8900
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Issuer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TREASURY BUILDING LOWER GRAND CANAL STREET DUBLIN 2 L2 00000
Business Address
Daniel William F (Reporting) CIK: 0001529409 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35238 | Film No.: 161636375